Strategies for Molecularly Enhanced Chemotherapy to Achieve Synthetic Lethality in Endometrial Tumors with Mutant p53
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2013-01-01
|
| Series: | Obstetrics and Gynecology International |
| Online Access: | http://dx.doi.org/10.1155/2013/828165 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849694588041691136 |
|---|---|
| author | Xiangbing Meng Don S. Dizon Shujie Yang Xinjun Wang Danlin Zhu Kristina W. Thiel Kimberly K. Leslie |
| author_facet | Xiangbing Meng Don S. Dizon Shujie Yang Xinjun Wang Danlin Zhu Kristina W. Thiel Kimberly K. Leslie |
| author_sort | Xiangbing Meng |
| collection | DOAJ |
| format | Article |
| id | doaj-art-fa1ca3b54f4546c09fa225d3f5b99cf2 |
| institution | DOAJ |
| issn | 1687-9589 1687-9597 |
| language | English |
| publishDate | 2013-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Obstetrics and Gynecology International |
| spelling | doaj-art-fa1ca3b54f4546c09fa225d3f5b99cf22025-08-20T03:20:01ZengWileyObstetrics and Gynecology International1687-95891687-95972013-01-01201310.1155/2013/828165828165Strategies for Molecularly Enhanced Chemotherapy to Achieve Synthetic Lethality in Endometrial Tumors with Mutant p53Xiangbing Meng0Don S. Dizon1Shujie Yang2Xinjun Wang3Danlin Zhu4Kristina W. Thiel5Kimberly K. Leslie6Department of Obstetrics and Gynecology, University of Iowa Hospitals and Clinics, Iowa City, IA 52242, USAGillette Center for Gynecological Oncology, Massachusetts General Hospital Cancer Center, Boston, MA 02114, USADepartment of Obstetrics and Gynecology, University of Iowa Hospitals and Clinics, Iowa City, IA 52242, USADepartment of Obstetrics and Gynecology, University of Iowa Hospitals and Clinics, Iowa City, IA 52242, USADepartment of Obstetrics and Gynecology, University of Iowa Hospitals and Clinics, Iowa City, IA 52242, USADepartment of Obstetrics and Gynecology, University of Iowa Hospitals and Clinics, Iowa City, IA 52242, USADepartment of Obstetrics and Gynecology, University of Iowa Hospitals and Clinics, Iowa City, IA 52242, USAhttp://dx.doi.org/10.1155/2013/828165 |
| spellingShingle | Xiangbing Meng Don S. Dizon Shujie Yang Xinjun Wang Danlin Zhu Kristina W. Thiel Kimberly K. Leslie Strategies for Molecularly Enhanced Chemotherapy to Achieve Synthetic Lethality in Endometrial Tumors with Mutant p53 Obstetrics and Gynecology International |
| title | Strategies for Molecularly Enhanced Chemotherapy to Achieve Synthetic Lethality in Endometrial Tumors with Mutant p53 |
| title_full | Strategies for Molecularly Enhanced Chemotherapy to Achieve Synthetic Lethality in Endometrial Tumors with Mutant p53 |
| title_fullStr | Strategies for Molecularly Enhanced Chemotherapy to Achieve Synthetic Lethality in Endometrial Tumors with Mutant p53 |
| title_full_unstemmed | Strategies for Molecularly Enhanced Chemotherapy to Achieve Synthetic Lethality in Endometrial Tumors with Mutant p53 |
| title_short | Strategies for Molecularly Enhanced Chemotherapy to Achieve Synthetic Lethality in Endometrial Tumors with Mutant p53 |
| title_sort | strategies for molecularly enhanced chemotherapy to achieve synthetic lethality in endometrial tumors with mutant p53 |
| url | http://dx.doi.org/10.1155/2013/828165 |
| work_keys_str_mv | AT xiangbingmeng strategiesformolecularlyenhancedchemotherapytoachievesyntheticlethalityinendometrialtumorswithmutantp53 AT donsdizon strategiesformolecularlyenhancedchemotherapytoachievesyntheticlethalityinendometrialtumorswithmutantp53 AT shujieyang strategiesformolecularlyenhancedchemotherapytoachievesyntheticlethalityinendometrialtumorswithmutantp53 AT xinjunwang strategiesformolecularlyenhancedchemotherapytoachievesyntheticlethalityinendometrialtumorswithmutantp53 AT danlinzhu strategiesformolecularlyenhancedchemotherapytoachievesyntheticlethalityinendometrialtumorswithmutantp53 AT kristinawthiel strategiesformolecularlyenhancedchemotherapytoachievesyntheticlethalityinendometrialtumorswithmutantp53 AT kimberlykleslie strategiesformolecularlyenhancedchemotherapytoachievesyntheticlethalityinendometrialtumorswithmutantp53 |